Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.
A machine learning (ML) model might retrain or drift between quarterly operational syncs. This means that, by the time an ...
Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will ...
In 2026, the competitive edge isn't where your data sits, but how fast it moves. We compare how the top five platforms are ...
Guidance for Q1 2026 -- Net revenue forecast between RMB 1.578 billion and RMB 1.598 billion, or 5.7%-7% growth rate, with ...
Jill Blumberg of Practical Law asked leading real estate practitioners to share their thoughts on recent developments impacting the US commercial real estate market.
In a corporate boardroom reviewing a high-stakes multinational deal, every financial risk was dissected — but no one in the room could see the classified ...
Recent transactions make clear that large pharmaceutical companies now view rare disease as a core area for sustained growth, rather than episodic deal-making. BioMarin’s acquisition of Amicus ...
The Israeli bombing that killed Iran’s Supreme Leader, Ayatollah Ali Khamenei, on Saturday not only brought the demise of one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results